Vitamin D ameliorates podocyte injury by enhancing autophagy activity in diabetic kidney disease

Abstract

Introduction: Restoration of podocyte autophagy is considered as a feasible strategy for the treatment of diabetic kidney disease (DKD). This study aimed at investigating the protective effect and potential mechanism of vitamin D on podocyte injury of DKD. Methods: Type 2 diabetic db/db mice received intraperitoneal injections of vitamin D analogue paricalcitol 400ng/kg per day for 16 weeks. Immortalized mouse podocytes were cultured in high glucose (HG) medium with active vitamin D3 calcitriol or autophagy inhibitor 3-methyladeine. Renal function and urine albumin creatinine ratio were assessed at week 24. HE, PAS staining and electron microscopy were used to evaluate renal histopathology and morphological changes. Immunohistochemistry, immunofluorescence and western blot were used to evaluate protein expression of nephrin and podocin in kidney tissue and podocytes. The expression of autophagy- related proteins (LC3, beclin-1, VPS34) and apoptosis-related proteins (cleaved caspase 3, Bax) was determined by western blotting. Podocyte apoptosis was further evaluated by using flow cytometer. Results: Albuminuria in a db/db mouse model was markedly attenuated after treatment with paricalcitol. This was accompanied by alleviation of mesangial matrix expansion and podocyte injury. Besides, the impaired autophagy in podocytes under diabetic conditions was also markedly enhanced after paricalcitol or calcitriol treatment, accompanied by restored decreased podocyte slit diaphragm proteins podocin and nephrin. Furthermore, the protective effect of calcitriol against HG induced podocyte apoptosis could be abated by autophagy inhibitor 3-methyladenine. Conclusion: Vitamin D ameliorates podocyte injury of DKD by enhancing podocyte autophagy activity, which may become a potential candidate autophagy activator for the therapeutic interventions for DKD.